(Q48433555)

11 February 2018

title

Effect of L-5-hydroxytryptophan on brain monoamine metabolism and evaluation of its clinical effect in depressed patients (English)

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

4 September 2023

author name string

S. Takahashi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1081591

4 September 2023

H. Kondo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1081591

4 September 2023

N. Kato

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1081591

4 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1081591

4 September 2023

publication date

1 November 1975

1 reference

11 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0022395675900254?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

https://api.elsevier.com/content/article/PII:0022395675900254?httpAccept=text/plain

4 September 2023

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

Journal of Psychiatric Research

4 September 2023

published in

1 reference

11 February 2018

volume

12

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

177-187

1 reference

11 February 2018

5-Hydroxytryptamine in the Hind-Brain of Depressive Suicides

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases.

4 September 2023

2

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania

4 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: A biochemical classification?

4 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

5-Hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis

4 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

Biogenic Amine Metabolites in Cerebrospinal Fluid of Depressed and Manic Patients

4 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

Abnormalities of indoleamines in affective disorders.

4 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique.

4 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan

4 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

FURTHER STUDIES ON: ONE DAY TREATMENT OF DEPRESSION WITH 5-HTP

4 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

Tryptophan in the treatment of depression.

4 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

5-H.T. metabolism in psychiatric syndromes.

4 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

5-Hydroxyindoleacetic Acid Levels in the Cerebrospinal Fluid of Depressive Patients treated with Probenecid

4 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

Effect of L-Tryptophan on Brain Serotonin Metabolism in Depressed Patients

4 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

Cerebrospinal Fluid Levels of MHPG in Affective Disorders

4 September 2023

16

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

Psychomotor Activity and Cerebrospinal Fluid Amine Metabolites in Affective Illness

4 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

Homovanillic and 5-Hydroxyindoleacetic Acid in Cerebrospinal Fluid of Depressed Patients

4 September 2023

18

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

Cerebrospinal fluid MHPG. An assessment of norepinephrine metabolism in affective disorders.

4 September 2023

19

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

Serotonin Metabolism in Rat Brain after Surgical Diversion of the Portal Venous Circulation

4 September 2023

21

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates

4 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

Neuropharmacology of the affective disorders

4 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

A rating scale for depression

4 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

Fluorimetric determination of 5-hydroxyindoleacetic acid in human urine and cerebrospinal fluid

4 September 2023

28

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

Measurement of acid monoamine metabolites in human and animal cerebrospinal fluid

4 September 2023

29

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

A sensitive and specific fluorescence assay for tissue serotonin

4 September 2023

30

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

Protein measurement with the Folin phenol reagent

4 September 2023

31

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

Clinical measurements of central dopamine and 5-hydroxytryptamine metabolism: reliability and interpretation of cerebrospinal fluid acid monoamine metabolite measures.

4 September 2023

32

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as antidepressant

4 September 2023

33

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

5-hydroxytryptophan for depression

4 September 2023

34

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

Interaction in the cerebral metabolism of the biogenic amines. Effect of phenelzine on this interaction

4 September 2023

36

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

L-dopa in Parkinsonism. A possible mechanism of action.

4 September 2023

37

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

L-dopa: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice.

4 September 2023

38

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

Reduced Catechol- O -Methyltransferase Activity in Red Blood Cells of Women with Primary Affective Disorder

4 September 2023

39

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

Differential Catechol-O-Methyltransferase Activity in Unipolar and Bipolar Affective Illness

4 September 2023

40

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

Amine precursors, amines, and false neurotransmitters in depressed patients.

4 September 2023

41

1 reference

https://api.crossref.org/works/10.1016/0022-3956(75)90025-4

4 September 2023

Identifiers

1 reference

11 February 2018

1 reference

11 February 2018